Hazlett, Burt & Watson’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31K Buy
77
+1
+1% +$452 0.01% 529
2025
Q4
$35K Sell
76
-4
-5% -$1.78K 0.01% 503
2025
Q3
$39K Buy
80
+9
+13% +$5.09K 0.01% 461
2025
Q2
$37K Sell
71
-19
-21% -$8.85K 0.02% 419
2025
Q1
$39K Hold
90
0.02% 388
2024
Q4
$44K Buy
90
+20
+29% +$10.5K 0.02% 373
2024
Q3
$35K Buy
70
+20
+40% +$10.7K 0.02% 398
2024
Q2
$30K Sell
50
-20
-29% -$11.3K 0.02% 402
2024
Q1
$40K Buy
70
+20
+40% +$11K 0.02% 356
2023
Q4
$26K Hold
50
0.02% 388
2023
Q3
$23K Hold
50
0.02% 395
2023
Q2
$22K Hold
50
0.02% 405
2023
Q1
$19K Hold
50
0.02% 394
2022
Q4
$16K Hold
50
0.01% 413
2022
Q3
$15K Hold
50
0.01% 417
2022
Q2
$15K Hold
50
0.01% 414
2022
Q1
$17K Buy
+50
New +$15.6K 0.01% 416

Other funds holding SNPS

Hazlett, Burt & Watson's SNPS Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its Synopsys (SNPS) stake by 1.3% in Q1 2026, buying an estimated $452 and bringing the position to 77 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #529.

Hazlett, Burt & Watson first reported a position in SNPS in Q1 2022 and has held it in 17 quarters since. The position peaked at $44K in Q4 2024. 1,391 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Hazlett, Burt & Watson held 77 shares of Synopsys worth $31K as of Q1 2026.
  • Hazlett, Burt & Watson bought 1 Synopsys share in Q1 2026, an estimated $452.
  • Synopsys made up 0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #529 holding.
  • Hazlett, Burt & Watson first reported a position in Synopsys in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Synopsys position peaked at $44K in Q4 2024.
  • 1,391 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.